Brief: Transgene Says Data Confirms High Accuracy Of Cancer Vaccine TG4050

Transgene SA

15/05/2020 06:41

May 15 (Reuters) - TRANSGENE SA  TRNG.PA :
    * TRANSGENE AND NEC DEMONSTRATE HIGH ACCURACY OF AI-BASED
NEOANTIGEN PREDICTION FOR THE DESIGN OF INDIVIDUALIZED CANCER
VACCINE TG4050
    * DATA CONFIRM THAT PREDICTION ALGORITHM SUCCESSFULLY
IDENTIFIES
IMMUNOGENIC CANCER MUTATIONS

Source text for Eikon:  ID:nBw9ZgBsYa 
Further company coverage:  TRNG.PA 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))